Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Mirae Asset Gold ETF
Industry : Stock Exchanges
BSE Code
ISIN Demat
Book Value(
)
543781
INF769K01JP9
13.2731211
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GOLDETF
0
234.58
EPS(TTM)
Face Value(
)
Div & Yield %:
0
10
0
Back
Mangalam Drugs & Organics Ltd
Mangalam Drugs and Organics Ltd - Mangalam Drugs And Organics Limited - Reply to Clarification- Financial results
Jan 11,2024
The Exchange had sought clarification from Mangalam Drugs And Organics Limited for the quarter ended 30-Sep-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Statement of Cash Flow not submitted The response of the Company is enclosed.